BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 19699736)

  • 1. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats.
    Morán A; de Urbina AV; Martín ML; Rodríguez-Barbero A; Román LS
    Eur J Pharmacol; 2009 Oct; 620(1-3):90-6. PubMed ID: 19699736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.
    Morán A; Ortiz de Urbina AV; Martín ML; García M; Rodriguez-Barbero A; Dorado F; San Román L
    Eur J Pharmacol; 2008 Sep; 592(1-3):133-7. PubMed ID: 18644367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
    Calama E; Fernández MM; Morán A; Martín ML; San Román L
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats.
    Restrepo B; García M; Rodríguez-Barbero A; Román LS; Martin ML; Morán A
    Eur J Pharmacol; 2011 May; 659(1):37-44. PubMed ID: 21414306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation.
    Fernández MM; Morán A; Martín ML; San Román L
    Eur J Pharmacol; 2000 Aug; 401(2):221-7. PubMed ID: 10924930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat.
    Russell A; Banes A; Berlin H; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):179-87. PubMed ID: 12235249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
    Watts SW; Thompson JM
    J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats.
    Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L
    Pharmacology; 2004 Jun; 71(2):66-72. PubMed ID: 15118345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal vasoconstrictor response to 5-hydroxytryptamine in the in situ autoperfused rat kidney: involvement of angiotensin II and the 5-HT2 receptor activation.
    Morán A; Velasco C; Martín ML; San Román L
    Eur J Pharmacol; 1997 Jul; 330(2-3):205-11. PubMed ID: 9253955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
    Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
    Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats.
    García M; Morán A; Luisa Martín M; Barthelmebs M; San Román L
    Eur J Pharmacol; 2006 May; 537(1-3):126-34. PubMed ID: 16630608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of nitric oxide in fading of 5-hydroxytryptamine-induced vasocontraction in rat isolated vena portae smooth muscle.
    Datté JY; Offoumou MA
    J Pharm Pharm Sci; 2004 Jan; 7(1):1-7. PubMed ID: 15144728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.
    García-Pedraza JÁ; García M; Martín ML; Morán A
    Vascul Pharmacol; 2015 Sep; 72():172-80. PubMed ID: 26003124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
    Jeong CY; Choi JI; Yoon MH
    Eur J Pharmacol; 2004 Oct; 502(3):205-11. PubMed ID: 15476746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of 5-hydroxytryptamine-induced contraction in the chicken gastrointestinal tract.
    Kitazawa T; Ukai H; Komori S; Taneike T
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):157-68. PubMed ID: 16553644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats.
    Watts SW; Baez M; Webb RC
    J Pharmacol Exp Ther; 1996 May; 277(2):1103-13. PubMed ID: 8627522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium.
    Bhattacharya A; Schenck KW; Xu YC; Nisenbaum L; Galbreath E; Cohen ML
    J Pharmacol Exp Ther; 2004 May; 309(2):825-32. PubMed ID: 14724223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
    Calama E; Ortíz de Urbina AV; Morán A; Martín ML; San Román L
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT moduline: an endogenous inhibitor of 5-HT(1B/1D)-mediated contraction in pulmonary arteries.
    Murdoch R; Morecroft I; MacLean MR
    Br J Pharmacol; 2003 Mar; 138(5):795-800. PubMed ID: 12642380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.